Clinical Advisors
-
Dr. Tara AndersonDr Tara Anderson - Regional Facility Advisor
MBBS, FRACP, FRCPA
Dr. Anderson works as an infectious diseases physician and clinical microbiologist at the Royal Hobart Hospital (RHH), Tasmania. She has roles as the clinical lead for antimicrobial stewardship at the RHH, medical advisor of the RHH IPCU and specialist medical advisor of the Tasmanian IPCU. Her areas of interest are antimicrobial stewardship and infection prevention and control. She contributes to antimicrobial stewardship activities across Tasmania and is a committee member of the Australian Commission on Safety and Quality in Health Care's Antimicrobial Stewardship Committee.
-
Dr. Celia CooperDr Celia Cooper - Paediatric Advisor
BMBS, FRACP, GDPH
Dr. Cooper is the site clinical director and head of microbiology and infectious diseases at WCH Site, SA Pathology, in South Australia. Her research areas are paediatric and neonatal infections and antibiotic management. She is the founding chair of the Australian Commission on Safety and Quality in Health Care's Antimicrobial Stewardship Committee.
-
Ms. Susan Luu
Ms. Susan Luu is an experienced health programs manager with a long history of working in antimicrobial stewardship, pharmacy and eHealth. She is currently a consultant for the World Health Organisation (WHO) in Antimicrobial Resistance (AMR) and Essential Medicines, working in the WHO Viet Nam Office as the AMR focal point for strengthening the National Antimicrobial Stewardship Program in hospitals/community, and supporting One Health strategies to combat AMR. Susan is also involved in the implementation of a nationwide centralised drug procurement program and other rational use of medicines initiatives. She was the Director of Clinical Services for the Guidance Group and worked closely with NCAS on IT innovations and education for antimicrobial stewardship (AMS) pharmacists. She was involved in the design and implementation of the Guidance AMS Program in over 60 hospitals in Australia from 2008 to 2017. Susan holds a Masters of Public Health Degree and is a seasoned researcher with a keen interest in mixed methods research.
-
Professor Elizabeth Manias
RN, CertCritCare, BPharm, MPharm, MNurs, PhD, FACN (DLF), MPS, MSHPA
Professor Elizabeth Manias is a professor at the School of Nursing and Midwifery at Deakin University. She is also an honorary professor at the School of Health Sciences at the University of Melbourne and an adjunct professorial fellow at the Royal Melbourne Hospital. Elizabeth is a registered pharmacist and nurse. Her areas of expertise include: health communication; medication safety; medication adherence; and patient safety and risk management. Her research has demonstrated that interpersonal communication is pivotal to influencing medication safety in clinical practice. She has explored how health professionals communicate to structure their practices and guide their medication decisions.
-
Dr. Jo-Anne Manski-Nankervis
BSc (Hons), MBBS (Hons), PhD, FRACGP
Dr Jo-Anne Manski-Nankervis is a clinically active academic general practitioner (GP) at the Department of General Practice, Melbourne Medical School. She leads the Data driven quality improvement theme, which conducts innovative research into the development and implementation of technology to inform decision making in general-practice, and the use of data to describe and improve general-practice activity, with a focus on chronic disease management and antimicrobial stewardship. Dr Manski-Nankervis co-leads the Department of General Practice Data for Decisions program, incorporating the Patron database and development of tools that integrate with the electronic medical record to assist in evidence-based clinical decision making. She co-leads the Future Health Today program with Prof Jon Emery and A/Prof Craig Nelson at Western Health, a new technology platform for identification and management of chronic disease in general practice. She has developed a simulation laboratory which is been used to co-design and pilot tools for use in the general practice setting, and co-produces technology with health professionals and consumers. She was one of the first researchers granted access to the NPS MedicineInsight dataset which she has used to conduct studies on chronic kidney disease, type 2 diabetes and the impact of My Health Record use on outcomes for people with type 2 diabetes, osteoarthritis and people prescribed benzodiazepine medications. She has strong collaborations with national and international partners including Therapeutic Guidelines, National Centre for Antimicrobial Stewardship, Western Health, and the Department of General Practice and Primary Care, University of Glasgow. Dr Manski-Nankervis has over 30 peer-reviewed journal publications and has contributed to two national guidelines. Over the last five years she has been awarded more than $6,200,000 in grants, tenders, and contracts. She is an active member of the RACGP National Faculty of Specific Interests – Diabetes Network, an Early Career Researcher representative on the Melbourne Medical School Research Committee, University of Melbourne and RACGP Expert Committee - Research and member of the Pharmaceutical Benefits Scheme Advisory Committee.
-
Dr. Brendan McMullanDr Brendan McMullan - Paediatric Advisor
BMed (Hons), FRACP, FRCPA
Dr. McMullan is a paediatric infectious diseases specialist and microbiologist, working at the Sydney Children’s Hospital. Dr. McMullan chairs the hospital antimicrobial stewardship committee and provides advice for paediatric antimicrobial stewardship throughout the South East Sydney and Illawarra Local Health Districts. He is also a conjoint senior lecturer in the School of Women’s and Children’s Health at the University of New South Wales. Dr. McMullan is an active member of the Australasian Society for Infectious Diseases (ASID) paediatric and mycology special interest groups and has worked with the New South Wales Clinical Excellence Commission on sepsis and antimicrobial use. His research interests include antimicrobial stewardship, bacteraemia in children and fungal infections.
-
Adj. Clin. Associate Professor Mary O’ReillyAdj. Clin. Assoc. Professor Mary O’Reilly - Hospital in the Home Advisor
MBBS, MPH, FRACP
Associate Professor O'Reilly is a physician and the director of the Departments of Infectious Diseases and Infection Prevention and Control at Eastern Health, Victoria. She is also an executive clinical director of Department of Ambulatory and Community Services at Eastern Health; an adjunct clinical associate professor in the Faculty of Medicine, Nursing and Health Sciences at Monash University; an infectious diseases physician for Cabrini; vice president of the Hospital in the Home Society (HITH) of Australasia; and an executive member of the Victorian Therapeutics Advisory Group. Her research interests include antimicrobial stewardship, infection prevention and control, HITH, and ambulatory care.